China Pharma Holdings, Inc.
CPHI
$1.75
-$0.035-1.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.82% | 0.63% | -43.76% | -142.51% | -100.82% |
| Total Depreciation and Amortization | -55.12% | -35.60% | 2.02% | 6.40% | 7.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.77% | -4,200.00% | 1,541.94% | 1,383.75% | 1,342.00% |
| Change in Net Operating Assets | 138.25% | 99.90% | -70.59% | 159.49% | 70.68% |
| Cash from Operations | 90.12% | 1,169.51% | -104.67% | 66.40% | 60.14% |
| Capital Expenditure | -- | -333.33% | 231.43% | 49.82% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -5,964.44% | 113.63% | -724.44% | -- |
| Total Debt Issued | -- | -99.36% | 133.66% | 55,411.11% | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.45% | -- | -- | -- | -- |
| Cash from Financing | -1,114.49% | -77.63% | 101.43% | 666.67% | -98.67% |
| Foreign Exchange rate Adjustments | 19.40% | -227.38% | 126.67% | 89.63% | -121.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.38% | -270.00% | -104.40% | 62.45% | 32.21% |